e-learning
resources
Berlin 2001
Sunday 23.09.2001
Estimation of quality of life and asthma control in children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Childhood asthma - symptom awareness and therapeutic options study
D. Richter, J. KeleČic, D. Tješic-Drinkovic, T. Voskresensky-BariČic, D. Barbir, B. Braun, L. Kukac (Zagreb, Croatia)
Source:
Annual Congress 2001 - Estimation of quality of life and asthma control in children
Session:
Estimation of quality of life and asthma control in children
Session type:
Oral Presentation
Number:
1005
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Richter, J. KeleČic, D. Tješic-Drinkovic, T. Voskresensky-BariČic, D. Barbir, B. Braun, L. Kukac (Zagreb, Croatia). Childhood asthma - symptom awareness and therapeutic options study. Eur Respir J 2001; 16: Suppl. 31, 1005
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
International perspectives on severe asthma: Current and future challenges in patient care
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Overweight children with asthma - are attribution of symptoms and treatment regimens appropriate?
Source: Eur Respir J 2002; 20: Suppl. 38, 333s
Year: 2002
Loneliness and lack of social support severely influences patients’ quality of life. Secondary findings from our focusgroup study in asthma and COPD patients
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Age-related differences in perceived asthma control in childhood: guidelines and reality
Source: Eur Respir J 2002; 20: 880-889
Year: 2002
4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
The effectiveness of patient education to improve adherence to the asthma treatment
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
A national database study of the effectiveness of switching real-life asthma patients to fostair
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
Developing integrated mental health and asthma treatment protocol using quality improvement methods
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
The impact of anxiety and depression on asthma-related health outcomes: A prospective study
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015
The impact of the addition of omalizumab on the utilization of healthcare resources by severe persistent asthma patients
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Dysfunctional breathing in asthma is associated with poor asthma control after specialist management
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
Parenting stress related to behavioural problems and disease severity in children with problematic severe asthma
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015
Adherence to asthma medication and preferences for once-daily treatment: Importance of treatment intrusiveness and patient beliefs
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Pharmacological strategies for self-management of asthma exacerbations
Source: Eur Respir J 2006; 28: 182-199
Year: 2006
Predicting asthma exacerbations in children – A real life observational study
Source: International Congress 2015 – Highlights in paediatric epidemiology: air pollution, asthma and primary ciliary dyskinesia
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept